Pfizer ropes in Meenakshi Nevatia as MD, Additional Director
S. Sridhar the current India Country President will be stepping down as Managing Director and Member of Board close of business hours on 31st March 2023.
Advertisement
Mumbai: Pfizer Limited announced that its Board of Directors has appointed Meenakshi Nevatia as an Additional Director and the Managing Director for a period of five years with effect from 3rd April 2023. She succeeds S.Sridhar, who announced his early retirement in August 2022.
Meenakshi is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and more recently with Stryker Corporation. Meenakshi has worked in over 8 countries (developed and emerging) and has held several General Management roles across multiple markets such as Thailand, Spain (Iberia) and India.
Meenakshi received her Bachelor’s in Science (Economics) from Presidency College, Kolkata, India and completed her Post Graduate Diploma in Management from the highly acclaimed Indian Institute of Management Ahmedabad (IIMA).
On this important Leadership appointment Pradip Shah, Chairman of the Board, Pfizer Limited said “This is a pivotal time for Pfizer in India, and I am pleased to welcome Meenakshi to take over the baton and set new benchmarks for the company and indeed the industry, I also wish to express my gratitude to Sridhar for his long years of service. His patient-centric vision contributed significantly to the growth of the company, increasing our reach to many more patients in the country and helping them benefit from the company’s drugs and therapies over the years.”
Nick Lagunowich, Global President, Emerging Markets Pfizer said, “India is critical to the healthcare ecosystem in the region and globally; it is a place where we aspire to bring many more breakthrough therapies and health solutions to patients across the economic segments. We are thrilled to welcome Meenakshi who comes at an important time when we are poised to scale up our contribution to the India Healthcare industry.”
The Board of Directors of Pfizer Limited, at their meeting held on 9th February 2023, considered the recommendation of the Nomination & Remuneration Committee, and approved the appointment of Meenakshi as the Managing Director w.e.f. 3 rd April 2023. S. Sridhar the current India Country President will be stepping down as Managing Director and Member of Board close of business hours on 31st March 2023.
The appointment of Meenakshi will be subject to approval of shareholders through Postal Ballot and central government.
Read also: S Sridhar resigns as MD of Pfizer
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.